Sequent Scientific plans to sell Specialty Chemicals Division
Transfer is subject to the approval of the shareholders of the company
BS B2B Bureau B2B Connect | Mumbai

The above said transfer is subject to the approval of the shareholders of the company.
SeQuent, which has a presence in different pharmaceutical verticals as well as specialty chemicals, recently signed an joint venture agreement with the Chennai based Shasun Pharmaceuticals to develop, manufacture and sell veterinary products including active pharmaceutical ingredients (APIs) and formulations in the global market.
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Mar 13 2014 | 3:59 PM IST